Placebo, Grofibrat S, 160 mg, tabletki powlekane clinical trials

Randomized, double-blind, multicenter, parallel group, placebo-controlled study to evaluate the efficacy and safety of phenofibrate treatment on the functions of beta cells in children and adolescents with newly diagnosed of type 1 diabetes

This study looks at how a medicine called phenofibrate might help children and teenagers newly diagnosed with type 1 diabetes. Researchers want to see if it can protect the cells in the body that make insulin, potentially helping them work better for longer.